Clinical Trials Browser

Phase 1/2 × Has announcements × Burkitt Lymphoma × Clear all

NCT04404660 2026-04-08

A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

Phase 1/2 Active not recruiting

153 enrolled 3 FDA

Burkitt Lymphoma, Recurrence